| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_199450d8e2d705a2b559ce4c32e5dcb3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5ddfbe14c0fbf9e847e35fed96f03f4f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_294e567850b28682b56038b743b32435
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4d907fe82bf11157799756b150542411
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_070787d818d3cfd7bb8a6b67b2c58788 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y102-01 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12P17-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-195
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N1-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N1-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-0008
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-0004
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-10 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P17-04 |
| filingDate |
2012-03-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_00fc5f3c6b28debab6bedd4d9a1712f0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_68ac40cff8cf5623cf5557462f4e7d77
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b82ccd14ac796bdb4fda5e73a0628c83
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ab34ecc7dd417b49940607204d6c431a |
| publicationDate |
2014-03-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2014073019-A1 |
| titleOfInvention |
Genetically modified cell and process for use of said cell |
| abstract |
The present invention relates to the field of biotransformation of furanic compounds. More particular the present invention relates to novel genetically modified cells with improved characteristics for biocatalytic transformation of furanic compounds and a vector suitable for the genetic modification of a host cell. Further aspects of the invention are aimed at processes for biotransformation of 5-(hydroxymethyl)furan-2-carboxylic acid (HMF-acid) and its precursors with the use of the cell according to the invention. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2022090153-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110651034-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11339414-B2 |
| priorityDate |
2011-03-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |